In the phase 3 PANOVA-3 trial, patients who underwent tumor-treating fields therapy had extended overall survival vs standard ...

Governor ‘Seyi Makinde marked his sixth year in office. Though there was no pomp or ceremony, the last 2,190 days have been defining as much as they were eventful for Oyo State, with many landmark ...

The Medical Association of Malta (MAM) is "very worried" about the status of the Medical Council, newly-elected association president Patrick Sammut told The Malta Independent on Sunday, noting that ...

Six young campaigners have launched fitness activities to get teenagers exercising more. The pupils, who are aged between 13 and 18, launched activities including girls-only gym, football, and rugby ...

This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the ...

Parathyroid problems masquerade as common problems of many other organs, misleading many medical specialists. The parathyroid ...

The Itovebi (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast ...

NEW HAVEN, CT and NEW YORK, NY, USA I May 31, 2025 I Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase ...

The historic, nearly 25-acre Mountain Meadow estate at 100 Cañada Road in Woodside is listed for $29.5M. It is the former ...

Housebuilders are celebrating news that plans to construct 4,115 homes near Cheltenham have been approved. The blueprint for ...

A trial of Incyte's Pemazyre in patients with FGFR-altered brain cancer did not meet its primary endpoint but had encouraging secondary outcomes.